23 Patents
- 0 cites
- 0 cites
- 0 cites
- US124911802025Application of Compound in Treating Pneumonia
SHENZHEN OPTIMUM BIOLOGICAL TECHNOLOGY CO., Ltd
0 cites - 0 cites
- US124212362025Seven-membered Heterocyclic Derivative Acting as KRAS G12C Mutant Protein Inhibitor
Medshine Discovery Inc.
0 cites - 0 cites
- 0 cites
- US1232569520255-(4-pyridyloxy)pyrazole Compounds Serving as Tgf-βr1 Kinase Inhibitor
JIANGSU AOSAIKANG PHARMACEUTICAL CO., Ltd.
0 cites - US123109482025Application of Monocyclic Β-lactam Compound in Pharmacy
SHENZHEN OPTIMUM BIOLOGICAL TECHNOLOGY CO., Ltd
0 cites - 0 cites
- US121227802024Pyrimidinyl Group-containing Tricyclic Compound Serving as C-met Inhibitor
JIANGSU AOSAIKANG PHARMACEUTICAL CO., Ltd.
0 cites - US121039362024Crystal Form of Hepatitis B Surface Antigen Inhibitor
FUJIAN AKEYLINK BIOTECHNOLOGY CO., Ltd.
0 cites - US120981272024Salt Form of Estrogen Receptor Downregulator, Crystalline Form Thereof, and Preparation Method Therefor
SHANDONG LUOXIN PHARMACEUTICAL GROUP STOCK CO., Ltd.
0 cites - 0 cites
- 0 cites
- US120180272024Macrocyclic Derivatives Acting as Xia Factor Inhibitor
China Resources Biopharmaceutical Company Limited
0 cites - US118076472023Crystal Form of Hepatitis B Surface Antigen Inhibitor and Application Thereof
FUJIAN AKEYLINK BIOTECHNOLOGY CO., Ltd.
0 cites - 0 cites
- US1169197420233,9-diazaspiro[5,5]undecane Compound as FLT3 and AXL Inhibitors
MEDSHINE DISCOVERY Inc.
0 cites - US116552482023Pyridone-pyrimidine Derivative Acting as KRAS G12C Mutein Inhibitor
MEDSHINE DISCOVERY Inc.
0 cites - 0 cites
- 0 cites